Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series D

Evolve BioSystems revolves to series D
UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.
Daily deal net: February 9, 2021
Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.
Soci cements $80m series D
Retail brand management business Soci has assembled $115m to date from investors including Stanford University's Daper Fund.
J-Pharma jacks series D up to $21m
Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.
Investors hook up Hinge Health with $300m
IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.
Gojo finds series D mojo
Tokyo University of Science helped extend Gojo & Company's series D round to $68.6m, lifting the microfinancing provider's overall funding to around $142m.
Investors endow Endomag with $20m
Existing backers including Draper Esprit and Sussex Place Ventures have reinvested to bring Endomag’s overall funding to above $43m.
Recursion takes $239m funding excursion
University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.

Other News

Climeworks stretches out for $110m close
ETH Zurich-founded carbon capture system producer Climeworks has added $35m to its latest round to fund further business growth.
StreetLight Data cruises into $15m series D
Osage University Partners has returned to bring the big urban transit data analytics company's funding total to more than $40m.
Ginger gives zest to series D
Cigna and Kaiser Permanente have participated in a $50m series D round for Ginger, bringing the MIT spinout's total funding to more than $120m.
PMV padlocks $70m series D
Osage University Partners-backed PMV has pushed its funding total to $236m as it further commercialises Princeton research stretching back to 1979.
J-Pharma takes in $16.3m
Osaka University Venture Capital was among the investors in a series D round for Kyorin University-founded cancer treatment developer J-Pharma.
Scalable Capital mounts $58m series D campaign
Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
test reg